Regenera Sciences

Biotechnology Research • • 1-10 Employees

Company overview

Headquarters	XX
Website	regenerasciences.com
NAICS	541714
Employees	1-10

Key Contact at Regenera Sciences

Rui Ferreira

Ceo & Partner

Regenera Sciences Email Formats

Regenera Sciences uses 1 email format. The most common is {first name} (e.g., john@regenerasciences.com), used 100% of the time.

Format	Example	Percentage
{first name}	john@regenerasciences.com	100%

About Regenera Sciences

Regenera’s stem cell-based therapies are a breakthrough in regenerative medicine, taking advantage of proprietary technology and experience resulting from over 20 years of academic and industry-driven research. Regenera® leverages a deep understanding of stem cell biology to formulate the best indicated stem cells to promote unprecedented musculoskeletal tissue regeneration. Regenera’s stem cell-based therapies have been widely validated in real clinical cases involving tendon and ligament lesions in high-performance horses and degenerative joint disease in dogs. Soon, we seek to use our disruptive technology to promote difficult wound healing, peripheral nerve regeneration, amelioration of cardiovascular and auto-immune conditions and many other applications. Regenera® stem cell-based therapies are also showing potential to be applied to humans, so we aim to translate our technology to human medicine. Our methodology involves the utmost ethics and respect for animal life, and we attempt to restore quality of life and eliminate pain in animals.

Regenera Sciences revenue & valuation

Annual revenue	$513,330
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$1,700,000
Total funding	No funding